Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique

References

• Darby S, McGale P, Correa C, Early Breast Cancer Trialists’ Collaborative G., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–1716.
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med. 1997;337(14):949–955. doi: 10.1056/NEJM199710023371401.
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337(14):956–962. doi: 10.1056/NEJM199710023371402.
   PubMed Web of Science ®Google Scholar
• McGale P, Taylor C, Correa C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–2135. doi: 10.1016/S0140-6736(14)60488-8.
   PubMed Web of Science ®Google Scholar
• Thorsen LB, Offersen BV, Danø H, et al. DBCG-IMN: a Population-Based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34(4):314–320. doi: 10.1200/JCO.2015.63.6456.
   PubMed Web of Science ®Google Scholar
• Thorsen LB, Thomsen MS, Berg M, et al. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects. Acta Oncol. 2014;53(8):1027–1034. doi: 10.3109/0284186X.2014.925579.
   PubMed Web of Science ®Google Scholar
• Kim J, Chang JS, Choi SH, et al. Radiotherapy for initial clinically positive internal mammary nodes in breast cancer. Radiat Oncol J. 2019;37(2):91–100. doi: 10.3857/roj.2018.00451.
   PubMed Web of Science ®Google Scholar
• Borm KJ, Simonetto C, Kundrát P, et al. Toxicity of internal mammary irradiation in breast cancer. Are concerns still justified in times of modern treatment techniques? Acta Oncol. 2020;59(10):1201–1209. doi: 10.1080/0284186X.2020.1787509.
   PubMed Web of Science ®Google Scholar
• Thorsen LBJ, Overgaard J, Matthiessen LW, et al. Internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the danish breast cancer group internal mammary node study. J Clin Oncol. 2022;40(36):4198–4206. doi: 10.1200/JCO.22.00044.
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Lax I, Fornander T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22(5):887–896. doi: 10.1016/0360-3016(92)90784-f.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998. doi: 10.1056/NEJMoa1209825.
   PubMed Web of Science ®Google Scholar
• Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–1649. doi: 10.1200/JCO.2016.72.0722.
   PubMed Web of Science ®Google Scholar
• Stovall M, Smith SA, Langholz BM, et al. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008;72(4):1021–1030. doi: 10.1016/j.ijrobp.2008.02.040.
   PubMed Web of Science ®Google Scholar
• Grantzau T, Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114(1):56–65. doi: 10.1016/j.radonc.2014.10.004.
   PubMed Web of Science ®Google Scholar
• Duane FK, McGale P, Teoh S, et al. International variation in criteria for internal mammary chain radiotherapy. Clin Oncol (R Coll Radiol). 2019;31(7):453–461. doi: 10.1016/j.clon.2019.04.007.
   PubMed Web of Science ®Google Scholar
• Hjelstuen MH, Mjaaland I, Vikström J, et al. Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol. 2012;51(3):333–344. doi: 10.3109/0284186X.2011.618510.
   PubMed Web of Science ®Google Scholar
• Ranger A, Dunlop A, Hutchinson K, et al. A dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain. Clin Oncol (R Coll Radiol). 2018;30(6):346–353. doi: 10.1016/j.clon.2018.01.017.
   PubMed Web of Science ®Google Scholar
• Ashby O, Bridge P. Late effects arising from volumetric modulated arc therapy to the breast: a systematic review. Radiography (Lond). 2021;27(2):650–653. doi: 10.1016/j.radi.2020.08.003.
   PubMedGoogle Scholar
• Dumane VA, Bakst R, Green S. Dose to organs in the supraclavicular region when covering the internal mammary nodes (IMNs) in breast cancer patients: a comparison of volumetric modulated arc therapy (VMAT) versus 3D and VMAT. PLoS One. 2018;13(10):e0205770. doi: 10.1371/journal.pone.0205770.
   PubMed Web of Science ®Google Scholar
• Alongi F, Giaj-Levra N, Fiorentino A, et al. Low-dose bath with volumetric modulated arc therapy in breast cancer: much ado about nothing? Tumori. 2016;102(4):335–336. doi: 10.5301/tj.5000516.
   PubMed Web of Science ®Google Scholar
• Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol. 2016;118(1):205–208. doi: 10.1016/j.radonc.2015.12.027.
   PubMed Web of Science ®Google Scholar
• Engstrøm KH, Brink C, Nielsen MH, et al. Automatic treatment planning of VMAT for left-sided breast cancer with lymph nodes. Acta Oncol. 2021;29:1–7.
   Google Scholar
• Offersen BV. The Skagen Trial 1 2015. Available from: https://www.dbcg.dk/PDF/SKAGEN_Trial1_protokol_ver_1.0_sept_2015_28.09.2015.pdf.
   Google Scholar
• Rossi M, Virén T, Heikkilä J, et al. The robustness of VMAT radiotherapy for breast cancer with tissue deformations. Med Dosim. 2021;46(1):86–93. doi: 10.1016/j.meddos.2020.09.005.
   PubMed Web of Science ®Google Scholar
• Prunaretty J, Bourgier C, Gourgou S, et al. Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy. Front Oncol. 2022;12:1066915. doi: 10.3389/fonc.2022.1066915.
   PubMed Web of Science ®Google Scholar
• Laugaard Lorenzen E, Christian Rehammar J, Jensen M-B, et al. Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977–2005. Radiother Oncol. 2020;152:103–110. doi: 10.1016/j.radonc.2020.08.007.
   PubMed Web of Science ®Google Scholar
• Moiseenko V, Einck J, Murphy J, et al. Clinical evaluation of QUANTEC guidelines to predict the risk of cardiac mortality in breast cancer patients. Acta Oncol. 2016;55(12):1506–1510. doi: 10.1080/0284186X.2016.1234067.
   PubMed Web of Science ®Google Scholar
• Gagliardi G, Constine LS, Moiseenko V, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl.):S77–S85. doi: 10.1016/j.ijrobp.2009.04.093.
   PubMed Web of Science ®Google Scholar
• Wennstig AK, Garmo H, Isacsson U, et al. The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors. Radiat Oncol. 2019;14(1):40. doi: 10.1186/s13014-019-1242-z.
   PubMedGoogle Scholar
• Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose–volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S70–S76. doi: 10.1016/j.ijrobp.2009.06.091.
   PubMed Web of Science ®Google Scholar
• Karlsen J, Tandstad T, Sowa P, et al. Pneumonitis and fibrosis after breast cancer radiotherapy: occurrence and treatment-related predictors. Acta Oncol. 2021;60(12):1651–1658. Decdoi: 10.1080/0284186X.2021.1976828.
   PubMed Web of Science ®Google Scholar
• Grantzau T, Overgaard J. Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients. Radiother Oncol. 2016;121(3):402–413. doi: 10.1016/j.radonc.2016.08.017.
   PubMed Web of Science ®Google Scholar
• Grantzau T, Thomsen MS, Væth M, et al. Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol. 2014;111(3):366–373. doi: 10.1016/j.radonc.2014.05.004.
   PubMed Web of Science ®Google Scholar
• Abo-Madyan Y, Aziz MH, Aly MM, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol. 2014;110(3):471–476. doi: 10.1016/j.radonc.2013.12.002.
   PubMed Web of Science ®Google Scholar
• Schneider U. Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Med Phys. 2009;36(4):1138–1143. doi: 10.1118/1.3089792.
   PubMed Web of Science ®Google Scholar
• Choi SH, Chang JS, Byun HK, et al. Risk of hypothyroidism in women after radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2021;110(2):462–472. doi: 10.1016/j.ijrobp.2020.12.047.
   PubMed Web of Science ®Google Scholar
• Johansen S, Fosså K, Nesvold IL, et al. Arm and shoulder morbidity following surgery and radiotherapy for breast cancer. Acta Oncol. 2014;53(4):521–529. doi: 10.3109/0284186X.2014.880512.
   PubMed Web of Science ®Google Scholar
• Rose J, Rodrigues G, Yaremko B, et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol. 2009;91(3):282–287. doi: 10.1016/j.radonc.2008.09.010.
   PubMed Web of Science ®Google Scholar
• Reidunsdatter RJ, Rannestad T, Frengen J, et al. Early effects of contemporary breast radiation on health-related quality of life – predictors of radiotherapy-related fatigue. Acta Oncol. 2011;50(8):1175–1182. doi: 10.3109/0284186X.2011.604345.
   PubMed Web of Science ®Google Scholar
• National action program with guidelines for diagnosis, treatment, and follow-up of patients with breast cancer. Norwegian, 2021. Available from: https://nbcgblog.files.wordpress.com/2021/03/nasjonalt-handlingsprogram-for-pasienter-med-brystkreft-01.03.2021-16-utgave.pdf.
   Google Scholar
• Xu Y, Ma P, Hu Z, et al. Non-coplanar volumetric modulated arc therapy for locoregional radiotherapy of left-sided breast cancer including internal mammary nodes. Radiol Oncol. 2021;55(4):499–507. doi: 10.2478/raon-2021-0045.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Crijns W, Hussein M, et al. Radiotherapy treatment plannINg study guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies. Radiother Oncol. 2020;153:67–78. doi: 10.1016/j.radonc.2020.09.033.
   PubMed Web of Science ®Google Scholar